Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Munson, E. L. Articles by Pfaller, M. A. Search for Related Content PubMed PubMed Citation Articles by Munson, E. L. Articles by Pfaller, M. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2002, p. 4281-4284, Vol. 40, No. 11
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.11.4281-4284.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Presumptive Identification of Candida kefyr on Levine Formulation of Eosin Methylene Blue Agar

Erik L. Munson,^1, Dennis R. Troy,¹ Joanne K. Weber,² Shawn A. Messer,¹ and Michael A. Pfaller^1*

Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242,¹ Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, Madison, Wisconsin 53706²

Received 4 April 2002/ Returned for modification 28 May 2002/ Accepted 30 July 2002

Top Abstract Text References

 
Three hundred thirty-one yeast and yeast-like isolates were cultivated on eosin methylene blue agar. While the sensitivity rate for Candida kefyr isolates producing a metallic green sheen was 81.8%, the high positive predictive value (100%) for yeast isolates with this phenotype belonging to C. kefyr suggests that these isolates can be presumptively identified as C. kefyr.

Top Abstract Text References

 
Although not isolated with the same relative frequency as yeast species like Candida albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis (15), Candida kefyr (formerly Candida pseudotropicalis) has been viewed as an emerging fungal pathogen (4, 5). Past medical literature has described cases of systemic disease that were elucidated postmortem (3, 13, 17, 20) and cases of cystitis (6) with C. kefyr as their etiology. More recent reports document C. kefyr as a confirmed agent of esophagitis (9) and fatal fungemia with disseminated disease (11) while suggesting a role for this organism in diseases of the reproductive tracts of infertile women (1).

Rapid and accurate yeast identification schemes have dated back to the 1960s with the development of the 2-h germ tube test for identification of C. albicans (10). Other methods not requiring the incubation period necessary for carbohydrate assimilation testing include those based on detection of pertinent enzymatic activities (14, 16). Colorimetric metabolic phenotypes demonstrated on CHROMagar Candida (CHROMagar Company, Paris, France) medium may yield presumptive identifications of C. albicans and C. tropicalis (12), while distinctive growth characteristics on eosin methylene blue (EMB) agar provide presumptive identifications of C. glabrata (2, 7; R. Jones, R. Master, and D. Powell, Abstr. 35th Intersci. Conf. Antimicrob. Agents Chemother., abstr. D10, 1995). This study shows further usefulness of EMB agar in the presumptive identification of C. kefyr.

Three hundred thirty-one clinical isolates were obtained from collections maintained by the University of Iowa College of Medicine and the University of Wisconsin Medical School. Concordant identification of the isolates were previously made by two independent sources using a variety of methods, including germ tube formation, carbohydrate assimilation testing using commercial methods, and distinctive colorimetric phenotype on CHROMagar Candida medium. This representative collection consisted of one genus of yeast-like filamentous fungi (Geotrichum spp.), one genus of yeast-like algae (Prototheca spp.), and 28 species of yeast (including six species comprising three yeast holomorphs). The number of C. albicans, C. glabrata, C. parapsilosis, and C. tropicalis isolates used in this investigation attempted to reflect their relative frequency of isolation in clinical disease (15).

Isolates were cryptically encoded and cultivated on potato dextrose agar plates (Remel, Lenexa, Kans.) for 48 to 72 h in 35°C ambient air. Isolated colonies were then subcultured onto two EMB agar plates (Remel) containing lactose as the sole carbohydrate source (Levine formulation [8]). One plate was incubated in 35°C ambient air, while the other was incubated at 35°C in 5% CO₂. Two independent parties (observers A and B) observed colonial growth at 48 and 96 h of incubation for evidence of a metallic green sheen, with a subset of randomly selected isolates (n = 285) also assessed for evidence of precipitate deposition. Isolates observed to exhibit a metallic green sheen were subcultured onto potato dextrose agar. Following 24 to 48 h of incubation in 35°C ambient air, the identities of these isolates were reconfirmed by use of the Yeast Biochemical Card (bioMérieux, Marcy l'Etoile, France). Differences in the rates of observation of metabolic activity (represented by the development of a dark central precipitate or the production of a metallic green sheen) were analyzed by the significance test of proportions (18). The alpha level was set at 0.05 before the experiments were started.

The observation of colonies producing a dark central precipitate in the agar, was not a strong predictor of organism identification for three reasons. First, analysis of 285 randomly selected isolates determined that incubation conditions had a significant impact on the deposition of a precipitate by an isolate. At the 48-h time point, both observers reported the presence of approximately twice as many isolates with precipitate deposition when incubation was done in a CO₂-enriched atmosphere than when incubation was done in ambient air (P < 0.001) (Table 1). This trend held true when isolates were observed after 96 h (P < 0.001). Exogenous atmospheric acidity induced by the carbon dioxide environment may provide an explanation for this phenomenon.

View this table: [in this window] [in a new window]

TABLE 1. Differences in interpretation of precipitate deposition of 285 randomly selected yeast and yeast-like species on EMB agar (Levine formulation)

Second, determination of precipitate deposition as an indicator of lactose fermentation, by yeast species on EMB medium may not be as straightforward as determination of patterns exhibited by coliforms of the family Enterobacteriaceae (8). When data recorded by observer A are compared to those of observer B for the 285-isolate subset, significant differences occurred in the percentage of isolates producing a precipitate at 48 h either in the presence (P < 0.001) or absence (P = 0.003) of CO₂ enrichment (Table 1). Differences in the data reported by the observers still existed at the 96-h time point, although only those differences from assays involving incubation in enriched CO₂ were significant (P = 0.021). A variety of sources (5, 7, 19) have actually documented a paucity of yeast species that are capable of fermenting lactose. Therefore, the precipitate observed in many of the isolates may actually be an artifact of the colony texture itself or may represent a topographical growth apex of the colony.

Finally, of 27 groups of organisms studied, 19 contributed at least one isolate that was deemed by both observers to exhibit a dark precipitate (Fig. 1A) following incubation in 35°C ambient air. Two yeast species, Candida inconspicua and Candida rugosa, contributed at least one isolate that produced a dark precipitate within colonial growth, as determined by only one of the observers. Isolates of six yeast or yeast-like species (Candida sake, Cryptococcus albidus, Cryptococcus neoformans, Cryptococcus terreus, Prototheca spp., and Saccharomyces spp.) failed to produce a dark precipitate (Fig. 1B).

View larger version (60K): [in this window] [in a new window]

FIG.1. Representative photographs of yeast species cultivated on the Levine formulation of EMB agar exhibiting the presence of a dark central precipitate (C. albicans) (A), the absence of a dark central precipitate (C. glabrata) (B), and a distinctive metallic green sheen (C. kefyr) (C).

In contrast, growth of yeast isolates on EMB agar that resulted in a distinctive metallic green sheen (Fig. 1C) appeared to be a strong diagnostic predictor. Of 331 yeast or yeast-like isolates, 18 (5.4%) exhibited this phenotype (Table 2). These isolates were identified as C. kefyr (one isolate was the Kluyveromyces marxianus teleomorph of C. kefyr), and the identifications were reconfirmed via a commercial system. Fifteen of these 18 isolates (83.3%) exhibited the phenotype at 48 h of incubation. Concordance between both observers was achieved for 96-h readings of isolates cultivated both in ambient air and in an enriched CO₂ environment. More isolates incubated in 35°C ambient air exhibited the characteristic sheen than did those incubated in a CO₂-enriched environment, although this difference was not statistically significant when all study isolates (P = 0.862) or all C. kefyr isolates (P = 0.708) were considered.

View this table: [in this window] [in a new window]

TABLE 2. Distribution of 331 yeast and yeast-like species and frequency of isolates exhibiting a metallic green sheen phenotype

While the positive predictive value for a green sheen colony being C. kefyr was 100% in this study, the sensitivity of the EMB agar screen for all isolates of C. kefyr tested was 81.8%. It was unclear why four C. kefyr strains did not exhibit this phenotype. Some C. kefyr strains have differential lactose-metabolizing capabilities (5, 19). However, subsequent analysis of the four strains on the confirmatory commercial system showed that the isolates did possess the ability to utilize lactose.

In conclusion, while production of a dark precipitate on EMB agar (Levine formulation) may not be predictive of specific yeast species, data from this study suggest that isolation of yeast populations that produce a metallic green sheen can yield a presumptive identification of C. kefyr. This finding can augment the practice of laboratories that already incorporate this medium into certain workups, particularly those that use the medium to assist in the presumptive identification of C. glabrata.

 
We express sincere appreciation to Joel Carl for the photography.

 
* Corresponding author. Mailing address: University of Iowa College of Medicine, Department of Pathology, Clinical Microbiology Laboratories, 200 Hawkins Dr., C606B GH, Iowa City, IA 52242. Phone: (319) 384-9566. Fax: (319) 356-4916. E-mail: michael-pfaller{at}uiowa.edu.

Present address: Medical Science Laboratories, Wauwatosa, WI 53226.

Top Abstract Text References

 

1
1. Abu-Elteen, K. H., A. M. M. Abdul Malek, and N. A. Abdul Wahid. 1997. Prevalence and susceptibility of vaginal yeast isolates in Jordan. Mycoses 40:179-185.[Medline]
2
2. Bale, M. J., C. Yang, and M. A. Pfaller. 1997. Evaluation of growth characteristics on blood agar and eosin methylene blue agar for the identification of Candida (Torulopsis) glabrata. Diagn. Microbiol. Infect. Dis. 28:65-67.[CrossRef][Medline]
3
3. Benthe, V. D. 1955. Candidasepsis. Zentbl. Allg. Pathol. Pathol. Anat. 93:241-245.
4
4. Borg-von Zepelin, M., H. Eiffert, M. Kann, and R. Ruchel. 1993. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany. Mycoses 36:247-253.[Medline]
5
5. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.[Abstract]
6
6. Hodgin, U. G., Jr. 1969. Cystitis due to Candida pseudotropicalis. A persistent case secondary to bladder calculus. Rocky Mt. Med. J. 66:30-32.
7
7. Larone, D. H. 1995. Medically important fungi: a guide to identification, 3rd ed., p. 67-76. American Society for Microbiology, Washington, D.C.
8
8. Levine, M. 1918. Differentiation of B. coli and B. aerogenes on a simplified eosin- methylene blue agar. J. Infect. Dis. 23:43-47.
9
9. Listemann, H., K. D. Schulz, R. Wasmuth, F. Begemann, and W. Meigel. 1998. Oesophagitis caused by Candida kefyr. Mycoses 41:343-344.[Medline]
10
10. Mackenzie, D. W. R. 1962. Serum tube identification of Candida albicans. J. Clin. Pathol. 15:563-565.
11
11. Morgan, M. A., C. J. Wilkowske, and G. D. Roberts. 1984. Candida pseudotropicalis fungemia and invasive disease in an immunocompromised patient. J. Clin. Microbiol. 20:1006-1007.[Abstract/Free Full Text]
12
12. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.[Abstract/Free Full Text]
13
13. Parker, J. C., J. J. McCloskey, and K. A. Kramer. 1976. Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host. Am. J. Clin. Pathol. 65:991-1000.[Medline]
14
14. Perry, J., G. R. Miller, and D. L. Carr. 1990. Rapid colorimetric identification of Candida albicans. J. Clin. Microbiol. 28:614-615.[Abstract/Free Full Text]
15
15. Pfaller, M. A., D. J. Diekema, R. N. Jones, H. S. Sader, A. C. Fluit, R. J. Hollis, S. A. Messer, and the SENTRY Participant Group. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39:3254-3259.[Abstract/Free Full Text]
16
16. Quindós, G., V. Lipperheide, and J. Pontón. 1993. Evaluation of two commercialized systems for the rapid identification of medically important yeasts. Mycoses 36:299-303.[Medline]
17
17. Skobel, P., D. Jorke, and G. Schabinski. 1955. Generalisierte Mykose; Sepsis durch Candida pseudotropicalis. Muench. Med. Wochenschr. 97:194-197.
18
18. Triola, M. F. 1992. Elementary statistics, 5th ed., p. 367-372. Addison-Wesley, Boston, Mass.
19
19. Warren, N. G., and K. C. Hazen. 1999. Candida, Cryptococcus, and other yeasts of medical importance, p. 1184-1199. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
20
20. Wegmann, T. 1964. Pilzerkrankungen der inneren Organe als Folge von Behandlung mit Antibiotica, unter besonderer Berucksichtigung der Respirationstraktes. Antibiot. Chemother. (Basel) 1:235-238.

---

Journal of Clinical Microbiology, November 2002, p. 4281-4284, Vol. 40, No. 11
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.11.4281-4284.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Munson, E. L. Articles by Pfaller, M. A. Search for Related Content PubMed PubMed Citation Articles by Munson, E. L. Articles by Pfaller, M. A.